Synergistic Ca2+ and Cu2+ requirements of the FGF1-S100A13 interaction measured by quartz crystal microbalance: An initial step in amlexanox-reversible non-classical release of FGF1

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1076-1085

  Matsunaga, Hayato ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Amlexanox; FGF1; Non classical release; Protein protein interaction; Quartz crystal microbalance; S100A13

Indexed keywords

AMLEXANOX; CALCIUM; COPPER; FIBROBLAST GROWTH FACTOR 1; METAL ION; PROTEIN; S100A13 PROTEIN; UNCLASSIFIED DRUG; AMINOPYRIDINE DERIVATIVE; ANTIALLERGIC AGENT; PROTEIN S 100; S100A13 PROTEIN, HUMAN; SILICON DIOXIDE;

ARTICLE; BIOSENSOR; GRAVIMETRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; ANIMAL; BINDING COMPETITION; BINDING SITE; BIOASSAY; CALCIUM SIGNALING; DOSE RESPONSE; DRUG EFFECT; HUMAN; INSTRUMENTATION; KINETICS; METABOLISM; METHODOLOGY; MOLECULAR WEIGHT; NEUROCHEMISTRY; PHYSIOLOGY; SECRETION;

AMINOPYRIDINES; ANIMALS; ANTI-ALLERGIC AGENTS; BINDING SITES; BINDING, COMPETITIVE; BIOLOGICAL ASSAY; CALCIUM; CALCIUM SIGNALING; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 1; HUMANS; KINETICS; MOLECULAR WEIGHT; NEUROCHEMISTRY; QUARTZ; S100 PROTEINS;

EID: 40949086888     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.11.002     Document Type: Article

References (39)

1. Arnesano F., Banci L., Bertini I., Fantoni A., Tenori L., and Viezzoli M.S. Structural interplay between calcium(II) and copper(II) binding to S100A13 protein. Angew. Chem. Int. Ed. Engl. 44 (2005) 6341-6344
2. Bhattacharya S., Bunick C.G., and Chazin W.J. Target selectivity in EF-hand calcium binding proteins. Biochim. Biophys. Acta. 1742 (2004) 69-79
3. Bouchard R., Pattarini R., and Geiger J.D. Presence and functional significance of presynaptic ryanodine receptors. Prog. Neurobiol. 69 (2003) 391-418
4. Chan W.Y., Xia C.L., Dong D.C., Heizmann C.W., and Yew D.T. Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc. Res. Tech. 60 (2003) 600-613
5. Cleves A.E. Protein transports: the nonclassical ins and outs. Curr. Biol. 7 (1997) R318-R320
6. Daniel K.G., Harbach R.H., Guida W.C., and Dou Q.P. Copper storage diseases: Menkes, Wilsons, and cancer. Front. Biosci. 9 (2004) 2652-2662
7. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta. 1450 (1999) 191-231
8. Friesel R., and Maciag T. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 82 (1999) 748-754
9. García A.G., García-De-Diego A.M., Gandía L., Borges R., and García-Sancho J. Calcium signaling and exocytosis in adrenal chromaffin cells. Physiol. Rev. 86 (2006) 1093-1131
10. Heizmann C.W., Fritz G., and Schäfer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 7 (2002) d1356-d1368
11. Jackson A., Tarantini F., Gamble S., Friedman S., and Maciag T. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem. 270 (1995) 33-36
12. Landriscina M., Bagalá C., Mandinova A., Soldi R., Micucci I., Bellum S., Prudovsky I., and Maciag T. Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress. J. Biol. Chem. 276 (2001) 25549-25557
13. Landriscina M., Soldi R., Bagalá C., Micucci I., Bellum S., Tarantini F., Prudovsky I., and Maciag T. S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J. Biol. Chem. 276 (2001) 22544-22552
14. Landriscina M., Schinzari G., Di Leonardo G., Quirino M., Cassano A., D'Argento E., Lauriola L., Scerrati M., Prudovsky I., and Barone C. S100A13, a new marker of angiogenesis in human astrocytic gliomas. J. Neurooncol. 80 (2006) 251-259
15. LaVallee T.M., Tarantini F., Gamble S., Mouta Carreira C., Jackson A., and Maciag T. Synaptotagmin-1 is required for fibroblast growth factor-1 release. J. Biol. Chem. 273 (1998) 22217-22223
16. Mandinov L., Mandinova A., Kyurkchiev S., Kyurkchiev D., Kehayov I., Kolev V., Soldi R., Bagala C., de Muinck E.D., Lindner V., Post M.J., Simons M., Bellum S., Prudovsky I., and Maciag T. Copper chelation represses the vascular response to injury. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6700-6705
17. Mandinova A., Soldi R., Graziani I., Bagala C., Bellum S., Landriscina M., Tarantini F., Prudovsky I., and Maciag T. S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells. J. Cell. Sci. 116 (2003) 2687-2696
18. Matsunaga H., and Ueda H. Evidence for serum-deprivation-induced co-release of FGF-1 and S100A13 from astrocytes. Neurochem. Int. 49 (2006) 294-303
19. 2+ channel activity regulates the interaction between FGF-1 and S100A13 for stress-induced non-vesicular release. Cell. Mol. Neurobiol. 26 (2006) 237-246
20. Mercer J.F. The molecular basis of copper-transport diseases. Trends. Mol. Med. 7 (2001) 64-69
21. Mouta Carreira C., LaVallee T.M., Tarantini F., Jackson A., Lathrop J.T., Hampton B., Burgess W.H., and Maciag T. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J. Biol. Chem. 273 (1998) 22224-22231
22. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270 (2003) 2109-2119
23. Okada M., Tokumitsu H., Kubota Y., and Kobayashi R. Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. Biochem. Biophys. Res. Commun. 292 (2002) 1023-1030
24. Osterloh D., Ivanenkov V.V., and Gerke V. Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization. Cell Calcium. 24 (1998) 137-151
25. Prudovsky I., Mandinova A., Soldi R., Bagala C., Graziani I., Landriscina M., Tarantini F., Duarte M., Bellum S., Doherty H., and Maciag T. The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell. Sci. 116 (2003) 4871-4881
26. Rajalingam D., Kumar T.K., Soldi R., Graziani I., Prudovsky I., and Yu C. Molecular mechanism of inhibition of nonclassical FGF-1 export. Biochemistry 44 (2005) 15472-15479
27. Reuss B., and von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313 (2003) 139-157
28. Ridinger K., Schäfer B.W., Durussel I., Cox J.A., and Heizmann C.W. S100A13: Biochemical characterization and subcellular localization in different cell lines. J. Biol. Chem. 275 (2000) 8686-8694
29. Schneggenburger R., and Neher E. Intracellular calcium dependence of transmitter release rates at a fast central synapse. Nature 406 (2000) 889-893
30. Schwarz T.L. Release of Neurotransmitters. In: Squire L.R., Bloom F.E., McConnell S.K., Roberts J.L., Spitzer N.C., and Zigmond M.J. (Eds). Fundamental Neuroscience. 2nd ed. (2003), Academic Press, Boston 197-224
31. Shishibori T., Oyama Y., Matsushita O., Yamashita K., Furuichi H., Okabe A., Maeta H., Hata Y., and Kobayashi R. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family. Biochem. J. 338 Pt 3 (1999) 583-589
32. Sivaraja V., Kumar T.K., Prudovsky I., and Yu C. Three-dimensional solution structure of a unique S100 protein. Biochem. Biophys. Res. Commun. 335 (2005) 1140-1148
33. Sivaraja V., Suresh Kumar T.K., Rajalingam D., Graziani I., Prudovsky I., and Yu C. Copper binding affinity of S100A13, a key component of the FGF-1 non-classical copper-dependent release complex. Biophys. J. 91 (2006) 1832-1843
34. Strausak D., Mercer J.F., Dieter H.H., Stremmel W., and Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res. Bull. 55 (2001) 175-185
35. Tarantini F., Gamble S., Jackson A., and Maciag T. The cysteine residue responsible for the release of fibroblast growth factor-1 residues in a domain independent of the domain for phosphatidylserine binding. J. Biol. Chem. 270 (1995) 29039-29042
36. Tarantini F., LaVallee T., Jackson A., Gamble S., Mouta Carreira C., Garfinkel S., Burgess W.H., and Maciag T. The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J. Biol. Chem. 273 (1998) 22209-22216
37. 2+ release. J. Neurophysiol. 92 (2004) 135-143
38. Verkhratsky A. The endoplasmic reticulum and neuronal calcium signalling. Cell Calcium. 32 (2002) 393-404
39. Zimmer D.B., Wright Sadosky P., and Weber D.J. Molecular mechanisms of S100-target protein interactions. Microsc. Res. Tech. 60 (2003) 552-559